Your browser doesn't support javascript.
loading
Improved catheter delivery for aspiration thrombectomy using Tenzing 7 ledge reducing catheter and FreeClimb 70.
Settecase, Fabio; Kim, Warren T; Sivapatham, Thinesh; Khangura, Rajkamal; Caldwell, James; Lee, Shane; Hixson, H Robert; Hoss, Daniel; English, Joey D.
Afiliación
  • Settecase F; Neurointerventional Surgery, California Pacific Medical Center, San Francisco, CA, USA.
  • Kim WT; Neurointerventional Surgery, Mills-Peninsula Medical Center, Burlingame, CA, USA.
  • Sivapatham T; Neurointerventional Surgery, California Pacific Medical Center, San Francisco, CA, USA.
  • Khangura R; Neurointerventional Surgery, Mills-Peninsula Medical Center, Burlingame, CA, USA.
  • Caldwell J; Neurointerventional Surgery, Christiana Care Health System, Newark, DE, USA.
  • Lee S; Neurointerventional Radiology, Sutter Sacramento Medical Center, Sacramento, CA, USA.
  • Hixson HR; Diagnostic & Interventional Neuroradiology, Auckland City Hospital, Auckland, New Zealand.
  • Hoss D; Diagnostic & Interventional Neuroradiology, Auckland City Hospital, Auckland, New Zealand.
  • English JD; Neurointerventional Surgery, Fort Sanders Regional Medical Center, Knoxville, TN, USA.
Interv Neuroradiol ; : 15910199231177754, 2023 May 28.
Article en En | MEDLINE | ID: mdl-37246314
ABSTRACT

PURPOSE:

Previous comparative mechanical thrombectomy device trials reported a substantial crossover rate from first-line aspiration to stent-retriever thrombectomy. A specialized delivery catheter may help track large-bore aspiration catheters to target occlusions. We report our multicenter experience of aspiration thrombectomy of intracranial large vessel occlusions using the FreeClimbTM 70 and Tenzing® 7 delivery catheter (Route 92, San Mateo, CA).

METHODS:

After local Institutional Review Board approval, we retrospectively reviewed the clinical, procedural, and imaging data of patients who underwent mechanical thrombectomy with the FreeClimb 70 and Tenzing 7.

RESULTS:

FreeClimb 70 was successfully delivered using Tenzing 7 to target occlusion in 30/30 (100%) patients (18 M1, 6 M2, 4 ICA-terminus, and 2 basilar artery occlusions), without the use of a stent-retriever for anchoring. In 21/30 (70%) cases, a leading microwire was not needed to advance the Tenzing 7 to the target. Median (interquartile range) time from groin puncture to first pass was 12 (interquartile range 8-15) minutes. Overall first pass effect, or first pass effect (modified thrombolysis in cerebral ischemia 2C-3), was achieved 16/30 (53%). For M1 occlusions, first pass effect was 11/18 (61%). Successful reperfusion (modified thrombolysis in cerebral ischemia ≥ 2B) was achieved in 29/30 (97%) cases after a median of 1 pass (interquartile range 1-3). Median groin puncture to reperfusion time was 16 (interquartile range 12-26) minutes. There were no procedural complications or symptomatic intracranial hemorrhage. Average improvement in National Institutes of Health Stroke Scale at discharge was 6.6 ± 7.1. There were three patient deaths (renal failure, respiratory failure, and comfort care).

CONCLUSIONS:

Initial data support the use of Tenzing 7 with FreeClimb 70 catheter for reliable access to rapid, effective, and safe aspiration thrombectomy of large vessel occlusions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Interv Neuroradiol Asunto de la revista: NEUROLOGIA / RADIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Interv Neuroradiol Asunto de la revista: NEUROLOGIA / RADIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos